Skip to main content
. 2020 Sep 3;15(9):e0238177. doi: 10.1371/journal.pone.0238177

Table 1. Characteristics of patients with renal hyperfiltration (RHF).

No RHF (N = 54,481) RHF(N = 1,511) P
Age (years) 46.8±12.4 46.2±12.7 0.040
Men (%) 28,587 (52.5) 765 (50.6) 0.157
BMI (kg/m2) <0.001
<20 6,322 (11.6) 245 (16.4)
20–24 29,729 (54.7) 776 (52.1)
25–29 16,177 (29.8) 394 (26.4)
≥30 2,143 (3.9) 75 (5.0)
SBP (mmHg) 115.7±14.0 115.0±15.3 0.064
≥130 11,450 (21.0) 371 (24.6) 0.001
eGFR (ml/min/1.73m2) 86.5±13.7 126.5±14.1 <0.001
BUN (mg/dL) 13.1±3.7 11.6±3.3 <0.001
Proteinuria (%) 3,120 (5.8) 114 (7.6) 0.003
Hematuria (%) 4,428 (8.2) 127 (8.4) 0.716
Hb (g/dL) 14.3±1.6 13.9±1.7 <0.001
WBC (/mm3) 5.99±2.05 6.04±1.78 0.286
Monocyte count (/mm3) 0.40±0.15 0.43±0.17 <0.001
ESR (mm/hr) 8.4±8.2 10.5±11.6 <0.001
CRP (mg/L) 1.7±5.4 2.6±10.3 0.006
AST (IU/L) 25.1±17.2 28.7±34.2 <0.001
ALT(IU/L) 25.5±25.1 28.0±24.8 <0.001
ALP(IU/L) 59.5±20.2 67.1±27.8 <0.001
GGT(IU/L) 36.6±55.0 47.4±98.0 <0.001
Bilirubin (mg/dL) 0.8±0.4 0.8±0.5 0.682
FBS (mg/dL) 95.6±20.8 101.2±32.0 <0.001
Albumin (g/dL) 4.5±0.3 4.4±0.3 <0.001
Triglyceride (mg/dL) 129.7±91.6 129.1±105.2 0.818
HDL cholesterol (mg/dL) 52.7±12.8 51.6±12.9 0.001
HTN (%) 8,802 (16.2) 255 (16.9) 0.456
DM (%) 3,219 (5.9) 164 (10.9) <0.001
CAD (%) 1,840 (3.4) 38 (2.5) 0.066
Cancer (%) 2,759 (5.1) 71 (4.7) 0.523

BMI, body mass index; SBP, systolic blood pressure; eGFR, estimated glomerular filtration rate; BUN, blood urea nitrogen; Hb, hemoglobin; WBC, white blood cell; ESR, erythrocyte sedimentation rate; CRP, C-reactive protein; AST, aspartate transaminase; ALT, aspartate aminotransferase; ALP, alkaline phosphatase; GGT, gamma-glutamyltransferase; FBS, fasting blood sugar; HDL, high density lipoprotein; hypertension, HTN; diabetes mellitus, DM; CAD, coronary artery disease.